Evidence map›Paper›PMID 30665943›Full record

ArticleEMBO reports2019

Mimicry by a viral RHIM.

Miguel Mompeán, Gunes Bozkurt, Hao Wu

Abstract readComment
In one paragraph

Article in EMBO reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. The role of RHIM in necroptosis.Biochemical Society transactions · 2022
    Article
  3. TAT-RHIM: a more complex issue than expected.The Biochemical journal · 2022
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Miguel MompeánInstituto Regional de Investigación Científica Aplicada (IRICA), University of Castile-La Mancha, Ciudad Real, Spain.ORCID 0000-0002-5608-3648
Gunes BozkurtDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.
Hao WuDepartment of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, MA, USA.

Funding

Structural & Functional Studies of TLR/IL-1R SignalingR37AI050872 · NIAID · BOSTON CHILDREN'S HOSPITAL · PI WU, HAO · 2012 to 2021
$4.7M
SMOCs: Novel Signal Transduction Complexes as New Targets for Drug DiscoveryDP1HD087988 · NICHD · BOSTON CHILDREN'S HOSPITAL · PI WU, HAO · 2015 to 2019
$4.4M
NIAID NIH HHS R37 AI050872NICHD NIH HHS DP1 HD087988
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AmyloidosisNecroptosisApoptosisHumansReceptor-Interacting Protein Serine-Threonine KinasesReceptor-Interacting Protein Serine-Threonine Kinases

Identifiers

PMID30665943
PMCPMC6362385

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.